Literature DB >> 9276721

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

G Wolf1, F N Ziyadeh, F Thaiss, J Tomaszewski, R J Caron, U Wenzel, G Zahner, U Helmchen, R A Stahl.   

Abstract

Glomerular influx of monocytes/macrophages (M/M) occurs in many immune- and non-immune-mediated renal diseases. The mechanisms targeting M/M into the glomerulus are incompletely understood, but may involve stimulated expression of chemokines. We investigated whether angiotensin II (ANG II) induces the chemokine RANTES in cultured glomerular endothelial cells of the rat and in vivo. ANG II stimulated mRNA and protein expression of RANTES in cultured glomerular endothelial cells. The ANG II-induced RANTES protein was chemotactic for human monocytes. Surprisingly, the ANG II-stimulated RANTES expression was transduced by AT2 receptors because the AT2 receptor antagonists PD 123177 and CGP-42112A, but not an AT1 receptor blocker, abolished the induced RANTES synthesis. Intraperitoneal infusion of ANG II (500 ng/h) into naive rats for 4 d significantly stimulated glomerular RANTES mRNA and protein expression compared with solvent-infused controls. Immunohistochemistry revealed induction of RANTES protein mainly in glomerular endothelial cells and small capillaries. Moreover, ANG II- infused animals exhibited an increase in glomerular ED-1- positive cells compared with controls. Oral treatment with PD 123177 (50 mg/liter drinking water) attenuated the glomerular M/M influx without normalizing the slightly elevated systolic blood pressure caused by ANG II infusion, suggesting that the effects on blood pressure and RANTES induction can be separated. We conclude that the vasoactive peptide ANG II may play an important role in glomerular chemotaxis of M/M through local induction of the chemokine RANTES. The observation that the ANG II- mediated induction of RANTES is transduced by AT2 receptors may influence the decision as to which substances might be used for the therapeutic interference with the activity of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276721      PMCID: PMC508279          DOI: 10.1172/JCI119615

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney.

Authors:  J Zhuo; K Song; P J Harris; F A Mendelsohn
Journal:  Ren Physiol Biochem       Date:  1992 Sep-Oct

2.  Renal injury from angiotensin II-mediated hypertension.

Authors:  R J Johnson; C E Alpers; A Yoshimura; D Lombardi; P Pritzl; J Floege; S M Schwartz
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

3.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8.

Authors:  A R Huber; S L Kunkel; R F Todd; S J Weiss
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

4.  Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes.

Authors:  Y Yamamoto; T Yamamguchi; M Shimamura; T Hazato
Journal:  Biochem Biophys Res Commun       Date:  1993-06-30       Impact factor: 3.575

5.  Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.

Authors:  R A Lafayette; G Mayer; S K Park; T W Meyer
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  Distribution of angiotensin II receptor subtypes in rat and human kidney.

Authors:  L A Sechi; E F Grady; C A Griffin; J E Kalinyak; M Schambelan
Journal:  Am J Physiol       Date:  1992-02

Review 7.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration.

Authors:  A Rot
Journal:  Immunol Today       Date:  1992-08

8.  Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes.

Authors:  P Heeger; G Wolf; C Meyers; M J Sun; S C O'Farrell; A M Krensky; E G Neilson
Journal:  Kidney Int       Date:  1992-01       Impact factor: 10.612

9.  Angiotensin II receptor subtypes in the kidney.

Authors:  R M Edwards; N Aiyar
Journal:  J Am Soc Nephrol       Date:  1993-04       Impact factor: 10.121

Review 10.  Angiotensin II as a renal growth factor.

Authors:  G Wolf; E G Neilson
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

View more
  42 in total

1.  Clinical trials report. Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Norman M Kaplan
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

Review 2.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

Review 3.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

Review 4.  Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.

Authors:  M Dalla Vestra; N Simioni; A Masiero
Journal:  Int Urol Nephrol       Date:  2008-10-29       Impact factor: 2.370

5.  Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension.

Authors:  Shantel A Vital; Satoshi Terao; Mutsumi Nagai; D Neil Granger
Journal:  Microcirculation       Date:  2010-11       Impact factor: 2.628

6.  Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Authors:  Sushrut S Waikar; Venkata Sabbisetti; Johan Ärnlöv; Axel C Carlsson; Josef Coresh; Harold I Feldman; Meredith C Foster; Gudeta D Fufaa; Johanna Helmersson-Karlqvist; Chi-Yuan Hsu; Paul L Kimmel; Anders Larsson; Yumin Liu; Lars Lind; Kathleen D Liu; Theodore E Mifflin; Robert G Nelson; Ulf Risérus; Ramachandran S Vasan; Dawei Xie; Xiaoming Zhang; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2016-06-07       Impact factor: 5.992

7.  Novel signaling mechanisms of intracellular angiotensin II-induced NHE3 expression and activation in mouse proximal tubule cells.

Authors:  X C Li; U Hopfer; J L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

Review 8.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.